CASP3 and neoplasm: When tumour cells were treated with TAS106 alone or X-irradiation with TAS106 under hypoxia, the activation of caspase-3 was weaker than that under normoxia, suggesting that hypoxic cells were resistant to caspase-mediated apoptosis.